ADMA Biologics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade ADMA Biologics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ADMA

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. 

CEO
Adam S. Grossman
CEOAdam S. Grossman
Employees
647
Employees647
Headquarters
Ramsey, New Jersey
HeadquartersRamsey, New Jersey
Founded
2004
Founded2004
Employees
647
Employees647

ADMA Key Statistics

Market cap
2.38B
Market cap2.38B
Price-Earnings ratio
16.38
Price-Earnings ratio16.38
Dividend yield
Dividend yield
Average volume
13.11M
Average volume13.11M
High today
$10.15
High today$10.15
Low today
$9.60
Low today$9.60
Open price
$9.67
Open price$9.67
Volume
1.31M
Volume1.31M
52 Week high
$25.67
52 Week high$25.67
52 Week low
$7.21
52 Week low$7.21

Stock Snapshot

With a market cap of 2.38B, ADMA Biologics(ADMA) trades at $10.00. The stock has a price-to-earnings ratio of 16.38.

During the trading session on 2026-04-09, ADMA Biologics(ADMA) shares reached a daily high of $10.15 and a low of $9.60. At a current price of $10.00, the stock is +4.2% higher than the low and still -1.5% under the high.

Trading activity shows a volume of 1.31M, compared to an average daily volume of 13.11M.

Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $25.67 and a low of $7.21.

Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $25.67 and a low of $7.21.

ADMA News

Simply Wall St 8h
A Look At ADMA Biologics Valuation After Short Seller Allegations And Legal Investigations

A short seller report from Culper Research accused ADMA Biologics (ADMA) of channel stuffing and inflating revenue growth, followed by multiple law firms launch...

A Look At ADMA Biologics Valuation After Short Seller Allegations And Legal Investigations
Simply Wall St 7d
Is ADMA Biologics Pricing Reflect Its Sharp Pullback And DCF Upside Potential

If you are trying to work out whether ADMA Biologics is attractively priced or not, the recent share moves give you plenty to think about. The stock last close...

Is ADMA Biologics Pricing Reflect Its Sharp Pullback And DCF Upside Potential

People also own

Based on the portfolios of people who own ADMA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.